Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

JAK-STAT-GO: Personalized, Targeted Therapy Options for Your IBD Patients

Access Activity

Overview / Abstract:

How can clinicians know they have current information for improving patients’ IBD outcomes? Expert faculty from the Icahn School of Medicine at Mount Sinai, University of Chicago Medicine and Biological Sciences, and Montefiore Medical Center/Albert Einstein College of Medicine recently led a symposium at a major gastroenterology meeting exploring the latest in treat-to-target paradigms, the role of the JAK-STAT pathway, and related research on investigational JAK inhibitors in IBD treatment. Video excerpts from the symposium are available as modules making it easier for the learner to move easily from one excerpt to another.

Expiration

Jun 27, 2020

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME

Format

Webinar / Webcast / Video

Credits / Hours

1.0

Accreditation

ACCME

Presenters / Authors / Faculty

Bruce Sands, MD, MS
Chief of the Dr. Henry D. Janowitz Division of Gastroenterology
Dr. Burrill B. Crohn Professor of Medicine
Icahn School of Medicine at Mount Sinai
Mount Sinai Health System
New York, NY

Joel Pekow, MD
Assistant Professor of Medicine, Section of Gastroenterology, Hepatology, and Nutrition
University of Chicago Medicine and Biological Sciences
Chicago, IL

Thomas Ullman, MD
Chief, Division of Gastroenterology
Montefiore Medical Center/Albert Einstein College of Medicine
Bronx, NY

Sponsors / Supporters / Grant Providers

Supported by an educational grant from Gilead Sciences, Inc.

Keywords / Search Terms

ACHL inflammatory disease, inflammatory bowel disease, IBD, crohn’s disease, ulcerative colitis, signaling pathway, JAK inhibitor, inflammatory diseases, autoimmune disorders, janus kinase, therapies, immune-mediated inflammatory diseases, JAK1, JAK2, JAK3, TYK2, JAK/STAT signaling, cytokine-mediated inflammatory diseases, DMARDs, chronic inflammation, emerging therapies, gastroenterology, digestive disorders, inflammatory bowel Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map